Photo credit: www.sciencedaily.com
New Insights into Serotonin Receptor Structure Offer Hope for Psychiatric Treatments
Researchers at the Max Delbrück Center, led by Misha Kudryashev, have made a significant breakthrough in understanding a molecular intermediate of a serotonin receptor linked to mental health disorders such as depression and schizophrenia. Their findings, detailed in The EMBO Journal, reveal a potential new target for therapeutic interventions.
The study highlights innovative approaches to treating psychiatric and gastrointestinal conditions that are inadequately managed by existing medications. Dr. Bianca Introini, along with her colleagues in the In Situ Structural Biology lab, successfully identified a stable intermediate form of the pentameric serotonin-gated 5-HT3A receptor, a protein embedded within cellular membranes. Kudryashev noted the extraordinary nature of this discovery, as isolating intermediates of assembling membrane proteins has traditionally posed significant challenges for researchers. This newly identified intermediate could open avenues for novel drug development.
Serotonin is a pivotal neurotransmitter known for its role in modulating various neural functions and psychological processes. Current pharmaceutical treatments that target serotonin receptors are common in psychiatric and neurological settings. Additionally, these medications are utilized to relieve nausea and vomiting associated with cancer treatment. Nonetheless, side effects frequently restrict their therapeutic application.
Among the seven identified serotonin receptors, the 5-HT3A receptor uniquely functions as an ion channel, serving as a regulatory conduit for the passage of select ions across cellular membranes. These ion channels are present in both the brainstem and gastrointestinal tract, forming essential circuits that manage digestive processes, relay sensory information, and trigger reflexive actions like vomiting.
Exploring Serotonin Receptor Structures
Cell membranes, which encase living cells, often contain proteins that facilitate signal transmission and the movement of substances across these barriers. The functionality of membrane proteins is vital; disruptions in their operations can lead to various diseases.
Some membrane proteins are multimeric, meaning they consist of multiple copies of the same molecule that assemble into a functional unit. Investigating the synthesis and assembly of these complex structures within cells is inherently challenging, particularly when it comes to studying intermediate forms.
For several years, Kudryashev’s team has diligently explored the atomic-level mechanics of how the serotonin receptor ion channel opens and closes in response to serotonin. To probe the receptor’s structure, they employ cryo-electron microscopy, a technique that utilizes electrons to capture images of frozen proteins or cell layers.
Unexpected Findings on Subunit Assembly
During their structural analysis of the 5-HT3A receptor, Dr. Introini discovered that certain formations were composed of four subunits arranged in a tetramer complex, deviating from the expected five-subunit structure typical of Cys-loop receptors. “This was curious,” noted Dr. Introini, considering that these receptors are conventionally formed as pentamers.
To further investigate the functional implications of these tetramers, the research team collaborated with scientists from The Research Center for Computer-aided Drug Discovery in Shenzhen, China. By employing computational simulations, they hypothesized that the tetramer serves as an intermediate form that subsequently transitions into the final pentameric configuration.
Remarkably, the tetramers were found to exist in two distinct states. One variant features a partially open extracellular domain, which simulation studies indicated may allow for the incorporation of the fifth subunit. This finding reinforces the notion that the tetramer operates as an intermediate molecule in the assembly process.
Implications for Future Research
Kudryashev emphasized the broader significance of their findings, stating, “The publication not only advances our understanding of the synthesis and assembly of these proteins and other multimeric proteins in membranes, but it also presents a promising alternative strategy for regulating cellular serotonin levels by targeting this intermediate protein.”
Overall, this research presents exciting opportunities for developing updated treatment modalities for psychiatric and gastrointestinal disorders, potentially enhancing therapeutic outcomes for patients struggling with these challenging conditions.
Source
www.sciencedaily.com